Overexpression of CPT1α attenuated NAFLD by activating β-oxidation [46], whereas HFD-fed CPT1α heterozygous knockout mice had more severe hepatic lipid accumulation [47]. This evidence concerns the gene CPT1A and metabolic dysfunction-associated steatotic liver disease.